![Nello Mainolfi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nello Mainolfi
Fundador en KYMERA THERAPEUTICS, INC. .
Fortuna: 20 M $ al 31/05/2024
Perfil
Nello Mainolfi is the founder of Kymera Therapeutics, Inc. which was founded in 2015.
He held the title of President, Chief Executive Officer & Director.
He is currently an Advisor at Atlas Venture Advisors, Inc. since 2018 and an Advisor at Atlas Venture Life Science Advisors LLC since 2018.
In the past, he worked as a Senior Director & Head-Drug Discovery at Raze Therapeutics, Inc. from 2015 to 2016.
Dr. Mainolfi obtained a doctorate degree from Imperial College London in 2004 and an undergraduate degree from Queen Mary University of London.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
18/06/2024 | 631 186 ( 1.03% ) | 20 M $ | 31/05/2024 |
Cargos activos de Nello Mainolfi
Empresas | Cargo | Inicio |
---|---|---|
KYMERA THERAPEUTICS, INC. | Fundador | 01/09/2015 |
Atlas Venture Advisors, Inc.
![]() Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Consultor / Asesor | 01/07/2018 |
Atlas Venture Life Science Advisors LLC
![]() Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | Consultor / Asesor | 01/07/2018 |
Antiguos cargos conocidos de Nello Mainolfi.
Empresas | Cargo | Fin |
---|---|---|
Raze Therapeutics, Inc.
![]() Raze Therapeutics, Inc. BiotechnologyHealth Technology Raze Therapeutics, Inc. engages in the discovery and development of oncology therapeutics. It offers a pipeline of one-carbon (1C) metabolism therapeutics across solid and hematologic cancers, including genetically-defined cancers. The company was founded by Vamsi Mootha, Joshua Rabinowitz, David Sabatini, and Adam Friedman on August 8, 2014 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/04/2016 |
Formación de Nello Mainolfi.
Queen Mary University of London | Undergraduate Degree |
Imperial College London | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
KYMERA THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 3 |
---|---|
Raze Therapeutics, Inc.
![]() Raze Therapeutics, Inc. BiotechnologyHealth Technology Raze Therapeutics, Inc. engages in the discovery and development of oncology therapeutics. It offers a pipeline of one-carbon (1C) metabolism therapeutics across solid and hematologic cancers, including genetically-defined cancers. The company was founded by Vamsi Mootha, Joshua Rabinowitz, David Sabatini, and Adam Friedman on August 8, 2014 and is headquartered in Cambridge, MA. | Health Technology |
Atlas Venture Advisors, Inc.
![]() Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Atlas Venture Life Science Advisors LLC
![]() Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | Finance |
- Bolsa de valores
- Insiders
- Nello Mainolfi